New clinical trial results reveal gedatolisib significantly improves progression-free survival in advanced HR+/HER2– breast ...

Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer ...

Celcuity shares jump as gedatolisib shows strong efficacy in HR+/HER2- breast cancer Phase 3 trial, with FDA filing expected ...

Celcuity recently released positive results from its phase 3 VIKTORIA-1 trial, and is raising both debt and shares. Read what ...

Early data from the DURIPANC study shows promising safety and survival benefits of rintatolimod and durvalumab for metastatic ...

As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...

The analysis of FDA-approved next-in-class drugs also found that, among RCTs with head-to-head trials, fewer than 1 in 4 of ...

In a randomized pilot study recently published in the Journal for ImmunoTherapy of Cancer, an international research team led ...

TACE combined with SBRT enhanced survival rates in patients with large hepatocellular carcinoma tumors, offering promising ...

Survival Mission Android Free. Fight for survival in Jericho: Survival Mission, a horror shooter with roguelike mechanics, ...

Corticosteroid use, particularly at high doses, decreases the effectiveness of ICI therapy in patients with non–small cell ...

Patients have been asking me about a recently published article that suggests a "'potential cure"' for myeloma is at hand.